Literature DB >> 22207689

Biogenesis of Weibel-Palade bodies in von Willebrand's disease variants with impaired von Willebrand factor intrachain or interchain disulfide bond formation.

Jiong-Wei Wang1, Dafna J Groeneveld, Guy Cosemans, Richard J Dirven, Karine M Valentijn, Jan Voorberg, Pieter H Reitsma, Jeroen Eikenboom.   

Abstract

BACKGROUND: Mutations of cysteine residues in von Willebrand factor are known to reduce the storage and secretion of this factor, thus leading to reduced antigen levels. However, one cysteine mutation, p.Cys2773Ser, has been found in patients with type 2A(IID) von Willebrand's disease who have normal plasma levels of von Willebrand factor. We hypothesize that disruption of either intra- or interchain disulfide bonds by cysteine mutations in von Willebrand factor has different effects on the biogenesis of Weibel-Palade bodies. DESIGN AND METHODS: The effect of specific cysteine mutations that either disrupt intrachain (p.Cys1130Phe and p.Cys2671Tyr) or interchain (p.Cys2773Ser) disulfide bonds on storage and secretion of von Willebrand factor was studied by transient transfection of human embryonic kidney cell line 293. Upon expression of von Willebrand factor these cells formed endothelial Weibel-Palade body-like organelles called pseudo-Weibel-Palade bodies. Storage of von Willebrand factor was analyzed with both confocal immunofluorescence and electron microscopy. Regulated secretion of von Willebrand factor was induced by phorbol 12-myristate 13-acetate.
RESULTS: p.Cys1130Phe and p.Cys2671Tyr reduced the storage of von Willebrand factor into pseudo-Weibel-Palade bodies with notable retention of von Willebrand factor in the endoplasmic reticulum, whereas p.Cys2773Ser-von Willebrand factor was stored normally. As expected, wild-type von Willebrand factor formed proteinaceous tubules that were seen under electron microscopy as longitudinal striations in pseudo-Weibel-Palade bodies. p.Cys2773Ser caused severe defects in von Willebrand factor multimerization but the factor formed normal tubules. Furthermore, the basal and regulated secretion of von Willebrand factor was drastically impaired by p.Cys1130Phe and p.Cys2671Tyr, but not by p.Cys2773Ser.
CONCLUSIONS: We postulate that natural mutations of cysteines involved in the formation of interchain disulfide bonds do not affect either the storage in Weibel-Palade bodies or secretion of von Willebrand factor, whereas mutations of cysteines forming intrachain disulfide bonds lead to reduced von Willebrand factor storage and secretion because the von Willebrand factor is retained in the endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22207689      PMCID: PMC3366651          DOI: 10.3324/haematol.2011.057216

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  40 in total

Review 1.  Cell biology of von Willebrand factor.

Authors:  D D Wagner
Journal:  Annu Rev Cell Biol       Date:  1990

2.  Localization of endogenous furin in cultured cell lines.

Authors:  J Shapiro; N Sciaky; J Lee; H Bosshart; R H Angeletti; J S Bonifacino
Journal:  J Histochem Cytochem       Date:  1997-01       Impact factor: 2.479

3.  Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin.

Authors:  J C Eikenboom; G Castaman; H L Vos; R M Bertina; F Rodeghiero
Journal:  Thromb Haemost       Date:  1998-04       Impact factor: 5.249

4.  Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease.

Authors:  R Schneppenheim; J Brassard; S Krey; U Budde; T J Kunicki; L Holmberg; J Ware; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  Cysteine-mutations in von Willebrand factor associated with increased clearance.

Authors:  C J Schooten; P Tjernberg; E Westein; V Terraube; G Castaman; J A Mourik; M J Hollestelle; H L Vos; R M Bertina; H M Berg; J C J Eikenboom; P J Lenting; C V Denis
Journal:  J Thromb Haemost       Date:  2005-10       Impact factor: 5.824

6.  Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.

Authors:  Sandra L Haberichter; Elizabeth P Merricks; Scot A Fahs; Pamela A Christopherson; Timothy C Nichols; Robert R Montgomery
Journal:  Blood       Date:  2004-08-26       Impact factor: 22.113

7.  New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance: von Willebrand disease type IIC Miami.

Authors:  M R Ledford; I Rabinowitz; J E Sadler; J W Kent; F Civantos
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

8.  Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.

Authors:  J C Eikenboom; T Matsushita; P H Reitsma; E A Tuley; G Castaman; E Briët; J E Sadler
Journal:  Blood       Date:  1996-10-01       Impact factor: 22.113

Review 9.  Biochemistry and genetics of von Willebrand factor.

Authors:  J E Sadler
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

10.  Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acids.

Authors:  J Voorberg; R Fontijn; J Calafat; H Janssen; J A van Mourik; H Pannekoek
Journal:  J Cell Biol       Date:  1991-04       Impact factor: 10.539

View more
  8 in total

1.  Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms.

Authors:  Ashley Cartwright; Simon J Webster; Annika de Jong; Richard J Dirven; Lisa D S Bloomer; Ahlam M Al-Buhairan; Ulrich Budde; Christer Halldén; David Habart; Jenny Goudemand; Ian R Peake; Jeroen C J Eikenboom; Anne C Goodeve; Daniel J Hampshire
Journal:  Blood Adv       Date:  2020-07-14

Review 2.  von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies.

Authors:  Paula D James; David Lillicrap
Journal:  Am J Hematol       Date:  2012-03-03       Impact factor: 10.047

3.  Insights into pathological mechanisms of missense mutations in C-terminal domains of von Willebrand factor causing qualitative or quantitative von Willebrand disease.

Authors:  Hamideh Yadegari; Julia Driesen; Anna Pavlova; Arijit Biswas; Vytautas Ivaskevicius; Robert Klamroth; Johannes Oldenburg
Journal:  Haematologica       Date:  2013-03-28       Impact factor: 9.941

Review 4.  Cysteines as Redox Molecular Switches and Targets of Disease.

Authors:  Annamaria Fra; Edgar D Yoboue; Roberto Sitia
Journal:  Front Mol Neurosci       Date:  2017-06-06       Impact factor: 5.639

5.  Variability of von Willebrand factor-related parameters in endothelial colony forming cells.

Authors:  Annika de Jong; Ester Weijers; Richard Dirven; Suzan de Boer; Jasmin Streur; Jeroen Eikenboom
Journal:  J Thromb Haemost       Date:  2019-07-22       Impact factor: 5.824

Review 6.  Von Willebrand Disease: From In Vivo to In Vitro Disease Models.

Authors:  Suzan de Boer; Jeroen Eikenboom
Journal:  Hemasphere       Date:  2019-09-27

7.  Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular disease.

Authors:  Suzan de Boer; Mackenzie Bowman; Colleen Notley; Aomei Mo; Patricia Lima; Annika de Jong; Richard Dirven; Ester Weijers; David Lillicrap; Paula James; Jeroen Eikenboom
Journal:  J Thromb Haemost       Date:  2020-08-18       Impact factor: 5.824

8.  Sec22b determines Weibel-Palade body length by controlling anterograde ER-Golgi transport.

Authors:  Ellie Karampini; Petra E Bürgisser; Jenny Olins; Aat A Mulder; Carolina R Jost; Dirk Geerts; Jan Voorberg; Ruben Bierings
Journal:  Haematologica       Date:  2021-04-01       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.